US equities |
TSLA $358.54 ▼-1.08% MU $896.38 ▼-3.74% NVDA $217.38 ▲+0.07% AAPL $344.90 ▲+0.85% SPCX $146.24 ▼-1.60% META $719.36 ▼-2.36% SNDK $1,329.93 ▼-4.65% MSFT $529.01 ▼-1.93%
FinancialContent

uniQure N.V. - Ordinary Shares (NQ:QURE)

22.02 -0.50 (-2.22%)
Delayed Quote Updated: 12:20 PM EDT, Oct 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about uniQure N.V. - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
UNIQURE N.V. QURE INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 37.3% Share Drop
From Kirby McInerney LLP
Via Business Wire
News headline image
QURE Investors Have Opportunity to Join uniQure N.V. Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
QURE Investor Alert: uniQure Securities Investigation - Kehoe Law Firm, P.C.
From Kehoe Law Firm
Via GlobeNewswire
News headline image
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Submission of Biologics License Application for Ifezuntirgene Inilparvovec (AMT-130) in Huntington’s Disease
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure to Announce Second Quarter 2026 Financial Results
~ uniQure to host earnings call on Wednesday, July 29, 2026 at 8:30 a.m. ET ~ 
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Closing of Upsized Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Pricing of Upsized $225 Million Public Offering
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces $150 Million Proposed Public Offering
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Plan for BLA Submission for AMT-130 in Huntington’s Disease
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces First Quarter 2026 Financial Results and Provides Recent Company Updates
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure Announces Successful UK MHRA Pre-Submission Meeting for AMT-130 in Huntington’s Disease
From uniQure Inc.
Via GlobeNewswire
News headline image
uniQure to Announce First Quarter 2026 Financial Results
From uniQure Inc.
Via GlobeNewswire
News headline image
QURE CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds uniQure (QURE) Investors of Securities Class Action Deadline on April 13, 2026
From Faruqi & Faruqi, LLP
Via Business Wire
News headline image
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
uniQure N.V. 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against uniQure N.V. - QURE
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
QURE Deadline: Rosen Law Firm Urges uniQure N.V. (NASDAQ: QURE) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
UNIQURE DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm Before April 13th
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
uniQure Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against uniQure N.V. - QURE
From SkyMedia, LLC
Via GlobeNewswire
News headline image
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
uniQure N.V. Securities Fraud Class Action Result of FDA Approval Delay and 49% Stock Decline - Investors may Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in uniQure N.V. of Class Action Lawsuit and Upcoming Deadlines – QURE
From Pomerantz LLP
Via GlobeNewswire
News headline image
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against uniQure N.V.
From Bernstein Liebhard LLP
Via GlobeNewswire
News headline image
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
News headline image
UNIQURE N.V. (NASDAQ: QURE) CLASS ACTION DEADLINE APPROACHING: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action by April 13, 2026
From Berger Montague
Via GlobeNewswire
News headline image
uniQure N.V. Class Action Reminder – Robbins LLP Encourages QURE Stockholders to Contact the Firm for Information About Their Rights
From Robbins LLP
Via Business Wire
News headline image
UNIQURE DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages uniQure N.V. Investors to Secure Counsel Before Important April 13 Deadline in Securities Class Action - QURE
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
UNIQURE DEADLINE APPROACHING: Bragar Eagel & Squire, P.C. Encourages uniQure N.V. Stockholders with Large Losses to Contact the Firm Before April 13th
From Bragar Eagel & Squire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9 10 Next >